BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33472941)

  • 1. Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes.
    Petrelli A; Atkinson MA; Pietropaolo M; Giannoukakis N
    Diabetes; 2021 Feb; 70(2):313-322. PubMed ID: 33472941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage.
    Nigi L; Maccora C; Dotta F; Sebastiani G
    Diabetes Metab Res Rev; 2020 May; 36(4):e3264. PubMed ID: 31850667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
    Citro A; Campo F; Dugnani E; Piemonti L
    Front Endocrinol (Lausanne); 2020; 11():606332. PubMed ID: 33628197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
    Tai N; Wong FS; Wen L
    J Autoimmun; 2016 Jul; 71():26-34. PubMed ID: 27021275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of the human pancreas in type-I diabetes.
    Richardson SJ; Willcox A; Bone AJ; Morgan NG; Foulis AK
    Semin Immunopathol; 2011 Jan; 33(1):9-21. PubMed ID: 20424842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
    Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
    Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
    Front Immunol; 2021; 12():667989. PubMed ID: 33953728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas.
    Atkinson MA; Mirmira RG
    Cell Metab; 2023 Sep; 35(9):1500-1518. PubMed ID: 37478842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes.
    Vecchio F; Messina G; Giovenzana A; Petrelli A
    Curr Diab Rep; 2019 Aug; 19(10):92. PubMed ID: 31471779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ donor specimens: What can they tell us about type 1 diabetes?
    Campbell-Thompson M
    Pediatr Diabetes; 2015 Aug; 16(5):320-30. PubMed ID: 25998576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.
    Kryvalap Y; Lo CW; Manuylova E; Baldzizhar R; Jospe N; Czyzyk J
    J Biol Chem; 2016 Jan; 291(1):266-78. PubMed ID: 26578518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes.
    Poudel A; Savari O; Striegel DA; Periwal V; Taxy J; Millis JM; Witkowski P; Atkinson MA; Hara M
    Endocrine; 2015 Aug; 49(3):693-702. PubMed ID: 25605478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
    Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas Pathology During the Natural History of Type 1 Diabetes.
    Rodriguez-Calvo T; Richardson SJ; Pugliese A
    Curr Diab Rep; 2018 Oct; 18(11):124. PubMed ID: 30293191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.
    Cheung SS; Metzger DL; Wang X; Huang J; Tai J; Tingle AJ; Ou D
    Pancreas; 2005 Mar; 30(2):105-14. PubMed ID: 15714132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pancreas in human type 1 diabetes.
    Rowe PA; Campbell-Thompson ML; Schatz DA; Atkinson MA
    Semin Immunopathol; 2011 Jan; 33(1):29-43. PubMed ID: 20495921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of innate immunity in triggering and tuning of autoimmune diabetes.
    Kim HS; Lee MS
    Curr Mol Med; 2009 Feb; 9(1):30-44. PubMed ID: 19199940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.
    Peters L; Posgai A; Brusko TM
    Clin Exp Immunol; 2019 Dec; 198(3):326-340. PubMed ID: 31309537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.
    Lind K; Hühn MH; Flodström-Tullberg M
    Clin Exp Immunol; 2012 Apr; 168(1):30-8. PubMed ID: 22385234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.